Dr. Jennifer Lynn Goralski, MD

Dr. Goralski practices at UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System.

Dr. Goralski's NPI, 1467611012, was assigned on June 7, 2008. Dr. Goralski graduated from Rutgers New Jersey Medical School in 2003. Dr. Goralski's North Carolina license number on file is 2008-00448.

Dr. Goralski's primary practice is UNC Hospitals, at 101 Manning Drive, Chapel Hill, NC 27514 in Orange County. The practice phone is (919) 966-4141.

Dr. Goralski's primary practice is UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System. The medical group on file is UNC Faculty Physicians. Dmand AI also links Dr. Goralski to 1 more therapy and rehab clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goralski practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Goralski's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Goralski is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Goralski's licenses on file in 2 states: North Carolina and New Jersey.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pulmonary fibrosis, sleep apnea and tobacco use among the conditions Dr. Goralski treats.

CMS data shows 77 Medicare services from Dr. Goralski across 4 procedure codes in 2024, for 48 Medicare patients. Medicare paid $6,607 for them.

CMS counts 48 Medicare patients who saw Dr. Goralski in 2024. The largest group is 65 to 74, with 16 patients. 73% of them have high blood pressure, and 65% have high cholesterol. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Goralski's median patient age at 63, with 62% women.

In 2024, Dr. Goralski wrote 194 Medicare Part D claims for 16 patients. CMS names the drug for 85 of them, across 4 drugs with 11 or more claims each, at $1,218,001 in total drug cost. In 2023, CMS named 111 claims across 5 drugs.

Dr. Goralski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Goralski as offering telehealth.

Dmand AI links 34 papers to Dr. Goralski, published from 2010 to 2025. 2014 was the busiest year, with 4. The most frequent topics are Cystic Fibrosis, Aminophenols and Quinolones. Dr. Goralski has published most often in J Cyst Fibros. Dr. Goralski's most frequent co-authors are Scott H. Donaldson, MD, Stephanie Duggins Davis, MD and Ahmet Z. Uluer, DO.

Dmand AI links Dr. Goralski to 3 clinical trials, 3 of them early phase 1 studies. Conditions studied include Cystic Fibrosis and Infant, Newborn, Diseases. University of North Carolina, Chapel Hill sponsors the most, 3.

CMS Open Payments shows 9 general payments to Dr. Goralski from 1 drug or device company in 2024. Speaker and faculty fees make up the largest share, 83% of the total. Vertex Pharmaceuticals Incorporated paid the most, $13,974.

Dr. Goralski graduated from Rutgers New Jersey Medical School in 2003.

Dr. Goralski is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.